Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
110.47
+1.20 (1.10%)
Sep 14, 2026, 4:00 PM EDT - Market closed

Inhibrx Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,6261,149223---
Market Cap Growth
305.94%415.39%----
Enterprise Value
1,6741,10328---
Last Close Price
110.4779.0015.40---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.13---
Forward PE
-0.200.20---
PS Ratio
-883.811114.65---
PB Ratio
-143.751.67---
P/TBV Ratio
-143.751.67---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-848.29142.16---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-3.4313.390.064.83-0.691.35
Net Debt / Equity Ratio
-0.91-2.15-1.08-1.56-0.69-1.16
Net Debt / EBITDA Ratio
-0.380.130.660.31-0.04-
Net Debt / FCF Ratio
-0.370.130.730.34-0.05-
Asset Turnover
-0.010.000.010.020.05
Inventory Turnover
55.7558.2929.9335.84--
Quick Ratio
4.763.683.764.950.015.85
Current Ratio
5.073.933.945.250.306.20
Return on Equity (ROE)
-1773.60%-197.85%1905.92%-1333.38%-511.61%-127.91%
Return on Assets (ROA)
-43.61%-51.58%-56.86%-84.42%-86.27%-32.53%
Return on Capital Employed (ROCE)
-101.30%-119.80%-158.70%-87.10%2794.40%-59.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.50%-12.19%757.00%---
FCF Yield
-8.11%-11.30%-88.37%---
Buyback Yield / Dilution
-0.61%-3.36%-27.17%70.62%-5.52%-50.47%
SEC Filings: 10-K · 10-Q